• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAI-1 调节 AT2 介导的再肺泡化和离子通透性。

PAI-1 regulates AT2-mediated re-alveolarization and ion permeability.

机构信息

Department of Cellular and Molecular Biology, Texas Lung Injury Institute, University of Texas at Tyler Health Science Center, Tyler, TX, USA.

Xinxiang Medical University, Xinxiang, Henan, China.

出版信息

Stem Cell Res Ther. 2023 Jul 27;14(1):185. doi: 10.1186/s13287-023-03414-4.

DOI:10.1186/s13287-023-03414-4
PMID:37501095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10375781/
Abstract

BACKGROUND

Acute lung injury is characterized by overwhelmingly elevated PAI-1 in both lung edema fluid and the circulating system. The role of increased PAI-1, encoded by Serpine1 gene, in the regeneration of injured lung epithelium has not been understood completely. This study aimed to investigate the role of Serpine1 in the regulation of alveolar type 2 epithelial cell (AT2) fate in a humanized mouse line carrying diseased mutants (Serpine1).

METHODS

Wild-type (wt) and Serpine1 AT2 cells were either cultured as monolayers or 3D alveolospheres. Colony-forming assay and total surface area of organoids were analyzed. AT1 and AT2 cells in organoids were counted by immunohistochemistry and fluorescence-activated cell sorting (FACS). To test the potential effects of elevated PAI-1 on the permeability in the epithelial monolayers, we digitized the biophysical properties of polarized AT2 monolayers grown at the air-liquid interface.

RESULTS

A significant reduction in total AT2 cells harvested in Serpine1 mice was observed compared with wt controls. AT2 cells harvested from Serpine1 mice reduced significantly over the wt controls. Spheroids formed by Serpine1 AT2 cells were lesser than wt control. Similarly, the corresponding surface area, a readout of re-alveolarization of injured epithelium, was markedly reduced in Serpine1 organoids. FACS analysis revealed a significant suppression in the number of AT2 cells, in particular, the CD44 subpopulation, in Serpine1 organoids. A lesser ratio of AT1:AT2 cells in Serpine1 organoids was observed compared with wt cultures. There was a significant increase in transepithelial resistance but not amiloride inhibition.

CONCLUSIONS

Our study suggests elevated PAI-1 in injured lungs downregulates alveolar epithelial regeneration by reducing the AT2 self-renewal, particularly in the CD44 cells.

摘要

背景

急性肺损伤的特征是肺水肿液和循环系统中 PAI-1 显著升高。编码 Serpine1 基因的 PAI-1 增加在受损肺上皮细胞的再生中的作用尚未完全理解。本研究旨在研究 Serpine1 在调节携带疾病突变体(Serpine1)的人源化小鼠系中肺泡 2 型上皮细胞(AT2)命运中的作用。

方法

野生型(wt)和 Serpine1 AT2 细胞分别在单层或 3D 肺泡球体中培养。分析集落形成试验和类器官的总表面积。通过免疫组织化学和荧光激活细胞分选(FACS)计数类器官中的 AT1 和 AT2 细胞。为了测试升高的 PAI-1 对上皮单层通透性的潜在影响,我们数字化了在气液界面生长的极化 AT2 单层的生物物理特性。

结果

与 wt 对照组相比,在 Serpine1 小鼠中观察到总 AT2 细胞的明显减少。从 Serpine1 小鼠中收获的 AT2 细胞明显少于 wt 对照组。Serpine1 AT2 细胞形成的球体也小于 wt 对照组。同样,相应的表面积,即受损上皮细胞再肺泡化的读数,在 Serpine1 类器官中明显降低。FACS 分析显示,在 Serpine1 类器官中,AT2 细胞数量,特别是 CD44 亚群显著减少。与 wt 培养物相比,Serpine1 类器官中的 AT1:AT2 细胞比例较低。跨上皮电阻显著增加,但阿米洛利抑制作用没有增加。

结论

我们的研究表明,受伤肺中的高 PAI-1 通过减少 AT2 自我更新,特别是在 CD44 细胞中,下调肺泡上皮细胞再生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/698bd5935ea3/13287_2023_3414_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/71afe03c211a/13287_2023_3414_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/7025458ddc89/13287_2023_3414_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/01a71c5e15a0/13287_2023_3414_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/7e412c74615f/13287_2023_3414_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/698bd5935ea3/13287_2023_3414_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/71afe03c211a/13287_2023_3414_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/7025458ddc89/13287_2023_3414_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/01a71c5e15a0/13287_2023_3414_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/7e412c74615f/13287_2023_3414_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ac/10375781/698bd5935ea3/13287_2023_3414_Fig5_HTML.jpg

相似文献

1
PAI-1 regulates AT2-mediated re-alveolarization and ion permeability.PAI-1 调节 AT2 介导的再肺泡化和离子通透性。
Stem Cell Res Ther. 2023 Jul 27;14(1):185. doi: 10.1186/s13287-023-03414-4.
2
PAI-1 regulates AT2-mediated re-alveolarization and ion permeability.纤溶酶原激活物抑制剂-1调节血管紧张素Ⅱ1型受体介导的再肺泡化和离子通透性。
Res Sq. 2023 Mar 1:rs.3.rs-2289657. doi: 10.21203/rs.3.rs-2289657/v1.
3
Wnt5a/β-catenin axis is involved in the downregulation of AT2 lineage by PAI-1.Wnt5a/β-catenin 轴参与了 PAI-1 对 AT2 谱系的下调。
Am J Physiol Lung Cell Mol Physiol. 2022 Nov 1;323(5):L515-L524. doi: 10.1152/ajplung.00202.2022. Epub 2022 Sep 13.
4
Prkg2 regulates alveolar type 2-mediated re-alveolarization.蛋白激酶G2调控2型肺泡细胞介导的再肺泡化。
Stem Cell Res Ther. 2022 Mar 21;13(1):111. doi: 10.1186/s13287-022-02793-4.
5
Humanized L184Q Mutated Surfactant Protein C Gene Alters Alveolar Type 2 Epithelial Cell Fate.人源化 L184Q 突变表面活性蛋白 C 基因改变肺泡 II 型上皮细胞命运。
Int J Mol Sci. 2024 Aug 9;25(16):8723. doi: 10.3390/ijms25168723.
6
[Establishment of a three-dimensional organoid culture system for mouse type 2 alveolar epithelial cells].[小鼠Ⅱ型肺泡上皮细胞三维类器官培养体系的建立]
Sheng Li Xue Bao. 2022 Aug 25;74(4):585-595.
7
Fraction of MHCII and EpCAM expression characterizes distal lung epithelial cells for alveolar type 2 cell isolation.MHCII 和 EpCAM 表达的分数特征化了用于分离肺泡 2 型细胞的远端肺上皮细胞。
Respir Res. 2017 Aug 7;18(1):150. doi: 10.1186/s12931-017-0635-5.
8
Knockout Mice Reveal a Major Role for Alveolar Epithelial Type I Cells in Alveolar Fluid Clearance.基因敲除小鼠揭示了肺泡Ⅰ型上皮细胞在肺泡液体清除中的主要作用。
Am J Respir Cell Mol Biol. 2016 Sep;55(3):395-406. doi: 10.1165/rcmb.2016-0005OC.
9
Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease.PM2.5 诱导的慢性阻塞性肺疾病小鼠模型中 AT2 向 AT1 细胞转化受损。
Respir Res. 2022 Mar 25;23(1):70. doi: 10.1186/s12931-022-01996-w.
10
CD8 T cell response and its released cytokine IFN-γ are necessary for lung alveolar epithelial repair during bacterial pneumonia.CD8 T 细胞反应及其释放的细胞因子 IFN-γ 是细菌性肺炎期间肺泡上皮修复所必需的。
Front Immunol. 2023 Oct 26;14:1268078. doi: 10.3389/fimmu.2023.1268078. eCollection 2023.

引用本文的文献

1
Development of delayed pulmonary toxicities and transcriptional changes in pre-existing interstitial lung disease mice after partial thoracic irradiation.部分胸部照射后,已存在间质性肺疾病小鼠的迟发性肺毒性发展及转录变化。
Radiat Oncol. 2025 Feb 7;20(1):20. doi: 10.1186/s13014-025-02596-w.
2
Alveolar Type 2 Epithelial Cell Organoids: Focus on Culture Methods.肺泡II型上皮细胞类器官:聚焦培养方法
Biomedicines. 2023 Nov 12;11(11):3034. doi: 10.3390/biomedicines11113034.
3
Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approach.

本文引用的文献

1
Wnt5a/β-catenin axis is involved in the downregulation of AT2 lineage by PAI-1.Wnt5a/β-catenin 轴参与了 PAI-1 对 AT2 谱系的下调。
Am J Physiol Lung Cell Mol Physiol. 2022 Nov 1;323(5):L515-L524. doi: 10.1152/ajplung.00202.2022. Epub 2022 Sep 13.
2
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.COVID-19 肺病与特发性肺纤维化具有相同的驱动 AT2 细胞病变的特征。
EBioMedicine. 2022 Aug;82:104185. doi: 10.1016/j.ebiom.2022.104185. Epub 2022 Jul 20.
3
Prkg2 regulates alveolar type 2-mediated re-alveolarization.
通过生物信息学和系统生物学方法展示 COVID-19 对代谢相关脂肪性肝病的影响。
Medicine (Baltimore). 2023 Sep 1;102(35):e34570. doi: 10.1097/MD.0000000000034570.
蛋白激酶G2调控2型肺泡细胞介导的再肺泡化。
Stem Cell Res Ther. 2022 Mar 21;13(1):111. doi: 10.1186/s13287-022-02793-4.
4
A molecular single-cell lung atlas of lethal COVID-19.致命性 COVID-19 的分子单细胞肺图谱。
Nature. 2021 Jul;595(7865):114-119. doi: 10.1038/s41586-021-03569-1. Epub 2021 Apr 29.
5
Divergent Regulation of Alveolar Type 2 Cell and Fibroblast Apoptosis by Plasminogen Activator Inhibitor 1 in Lung Fibrosis.纤溶酶原激活物抑制剂 1 对肺纤维化中肺泡 2 型细胞和成纤维细胞凋亡的不同调节作用。
Am J Pathol. 2021 Jul;191(7):1227-1239. doi: 10.1016/j.ajpath.2021.04.003. Epub 2021 Apr 20.
6
Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection.与 COVID-19 感染严重程度相关的炎症和血栓形成生物标志物。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621999099. doi: 10.1177/1076029621999099.
7
Fibrinolytic niche is required for alveolar type 2 cell-mediated alveologenesis via a uPA-A6-CD44-ENaC signal cascade.通过尿激酶型纤溶酶原激活剂-A6-细胞表面抗原CD44-上皮钠通道信号级联反应,2型肺泡细胞介导的肺泡形成需要纤维蛋白溶解微环境。
Signal Transduct Target Ther. 2021 Feb 27;6(1):97. doi: 10.1038/s41392-021-00511-9.
8
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.住院 COVID-19 患者的血浆组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1。
Sci Rep. 2021 Jan 15;11(1):1580. doi: 10.1038/s41598-020-80010-z.
9
Progenitor identification and SARS-CoV-2 infection in human distal lung organoids.人远端肺类器官中的祖细胞鉴定和 SARS-CoV-2 感染。
Nature. 2020 Dec;588(7839):670-675. doi: 10.1038/s41586-020-3014-1. Epub 2020 Nov 25.
10
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19.急性呼吸窘迫综合征(ARDS)中的纤维蛋白溶解异常和溶栓药物治疗 COVID-19 的多功能性。
J Thromb Haemost. 2020 Jul;18(7):1548-1555. doi: 10.1111/jth.14872. Epub 2020 Jun 3.